Elimination of lymphatic filariasis: do we have the drugs to complete the job?

Bockarie, Moses and Deb, Rinki (2010) 'Elimination of lymphatic filariasis: do we have the drugs to complete the job?'. Current Opinion in Infectious Diseases, Vol 23, Issue 6, pp. 617-620.

Full text not available from this repository.

Abstract

Alternative and effective MDA regimens and strategies will be needed if the GPELF is to achieve the goals of global elimination of lymphatic filariasis by 2020. Further research to test new drug regimens (including single high doses of albendazole) or alternative treatment regimens (including biannual treatment schedules) may also be necessary. A new drug, moxidectin, which is currently under development for use against onchocerciasis, may be effective against lymphatic filariasis.

Item Type:	Article
Subjects:	QV Pharmacology > Anti-Inflammatory Agents. Anti-Infective Agents. Antineoplastic Agents > QV 250 Anti-infective agents (General) QV Pharmacology > QV 34 Experimental pharmacology (General) WC Communicable Diseases > Tropical and Parasitic Diseases > WC 880 Filariasis and related conditions (General)
Faculty: Department:	Groups (2002 - 2012) > Disease Control Strategy Group
Digital Object Identifer (DOI):	https://doi.org/10.1097/QCO.0b013e32833fdee5
Related URLs:	http://journals.lww.com/co-infectiousdis...
Depositing User:	Users 322 not found.
Date Deposited:	22 Nov 2011 15:29
Last Modified:	06 Feb 2018 13:04
URI:	https://archive.lstmed.ac.uk/id/eprint/2411

Statistics

View details

Actions (login required)

Edit Item